Xencor Inc Catalyst Calendar

Proactively evaluate Xencor Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

A sample of Xencor Inc Catalyst Calendar data

Event Date Event Type Company Name Ticker Symbol Drug Name Therapy Area Indication Source Type
Showing 3 of 50+ results. Subscribe to unlock more.
31 Dec 2020 GDCTXXXX Lorem Lorem Lorem XXXX Planned Lorem
30 Jun 2020 Phase I Trial Results ICON Plc; Xencor Inc ICLR; XNCR tidutamab Oncology Gastrointestinal Stromal Tumor (GIST); Gastrointestinal Tumor; Lung Cancer; Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET); Neuroendocrine Tumors; Pancreatic Cancer; Solid Tumor Company Press Release
31 Dec 2019 IND Filing (US) Xencor Inc XNCR XmAb-306 Oncology - Company Press Release
31 Dec 2019 Phase I Trial Results ICON Plc; Xencor Inc ICLR; XNCR plamotamab Hematological Disorders; Oncology B-Cell Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia (CLL); Diffuse Large B-Cell Lymphoma; Extranodal Marginal Zone B-Cell Lymphoma (Mucosa-Associated Lymphoid Tissue or MALT-Lymphoma); Follicular Lymphoma; Hematological Tumor; Lymphoma; Mantle Cell Lymphoma; Nodal Marginal Zone B-Cell Lymphoma; Non-Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia (CLL); Relapsed Chronic Lymphocytic Leukemia (CLL); Splenic Marginal Zone B-Cell Lymphoma; Unspecified B-Cell Lymphomas; Unspecified Hematological Disorders; Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma) Company Presentation
Catalyst Calendar

Feature

Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.

Benefit

Access:

  • Trial Events for trials conducted globally by a company, university, institute or CRO:  Trial Initiation, Trial Completion, Trial Results
  • Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
  • Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)

Value

Proactively evaluate companies and catalyst impacts

Stay ahead of the competition & improve corporate planning

Bolster business development with timely opportunities

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer